Use of a Pharmaceutical combination of an aldosterone receptor antagonist and a neutral Endopeptidase Inhibitor,Useful for the treatment and Prevention of a Pathological condition associated with hypertension, renal Dysfunction, and insulinopatia, cardiovascular or Brain vascular.

摘要

Use of a combination of one or more of the aldosterone Receptor Antagonists and Inhibitors of one or more of the EPN,A combination of one or more Receptor Antagonists of aldosterone Inhibitors, one or more of the EPN, and one or more ACE InhibitorsOr a combination of one or more of the aldosterone Receptor Antagonists and one or more vasopeptidase Inhibitors for Therapeutic and / or prophylactic Treatment of a conditionHypertension, cardiovascular disease, renal Dysfunction, edema, cerebrovascular disease or Pathological condition of insulinopatia in a subject.